<

AFFLUENT MEDICAL Affluent Medical : Coverage initiation by Kepler Cheuvreux.

Transparency directive : regulatory news

14/04/2022 17:55

Affluent Medical
Affluent Medical : Coverage initiation by Kepler Cheuvreux.

14-Apr-2022 / 17:55 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


PRESS RELEASE

Aix-en-Provence, 14 April 2022 - 17:45

 

 

 

 

 

Coverage initiation by Kepler Cheuvreux

 

 

Affluent Medical (ISIN code: FR0013333077 - Ticker: AFME), a French medtech specialising in the international development and industrialisation of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and mitral valve pathology, announces today that Kepler Cheuvreux has initiated coverage of the stock.

 

Affluent Medical now benefits from Kepler Cheuvreux' coverage with the publication of a financial note entitled "Kill three birds with one stone". This new note completes the coverage of the stock and enriches the consensus of analysts alongside Swisslife and Invest Securities. The financial analysis is available on the website: https://www.keplercheuvreux.com/, under "Research Public Access".

 

About Affluent Medical

Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the pre-clinical and clinical study phase. Kalios is set to be the first medical device to be marketed in Europe.

For more information, please visit: www.affluentmedical.com

 

Contacts:

AFFLUENT MEDICAL

Jérôme GEOFFROY

Chief Financial and Administrative Officer

investor@affluentmedical.com

ACTIFIN, financial communication

Ghislaine GASPARETTO

+33 (0) 6 21 10 49 24

affluentmedical@actifin.fr

ACTIFIN, financial press relations

Jennifer JULLIA

+33 (0) 6 47 97 54 87

jjullia@actifin.fr

 

PRIMATICE, public relations France
Thomas ROBOREL de CLIMENS
+33 (0) 6 78 12 97 95

thomasdeclimens@primatice.com
 

 


Regulatory filing PDF file

File: Affluent Medical - Kepler Cheuvreux EN


Language: English
Company: Affluent Medical
320 avenue Archimède, Les pléiades III Bâtiment B
13100 Aix en Provence France
France
Phone: +33 4 42 95 12 20
E-mail: jerome.geoffroy@affluentmedical.com
Internet: https://www.affluentmedical.com/
ISIN: FR0013333077
Euronext Ticker: AFME
AMF Category: Inside information / Other releases
EQS News ID: 1328901
 
End of Announcement EQS News Service

1328901  14-Apr-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1328901&application_name=news&site_id=symex


Other stories

19/05/2024 11:28
19/05/2024 11:33
19/05/2024 11:18
19/05/2024 00:50
19/05/2024 00:55
19/05/2024 09:00
18/05/2024 22:21
19/05/2024 10:36
18/05/2024 19:31
18/05/2024 18:50
19/05/2024 09:49
19/05/2024 10:39
19/05/2024 08:00
19/05/2024 11:41
19/05/2024 02:03
17/05/2024 17:26
19/05/2024 02:41
18/05/2024 16:00
17/05/2024 21:00
17/05/2024 16:25
18/05/2024 02:32
18/05/2024 18:19
18/05/2024 20:57
19/05/2024 10:00
19/05/2024 11:03
19/05/2024 03:44
19/05/2024 11:17
19/05/2024 13:15
19/05/2024 09:01
19/05/2024 12:07
17/05/2024 15:34
18/05/2024 19:33
17/05/2024 17:00
18/05/2024 16:00
18/05/2024 20:51
19/05/2024 09:31
18/05/2024 19:16
19/05/2024 07:00